|
Suppliers for CAS
204005-46-9
|
Properties | | CAS |
204005-46-9 | | Formula |
C15H14N2O |
|
|
6 Registered suppliers
Hangzhou Keying Chem Co., Ltd.
P.R.China
H&Z Industry Co.,Ltd
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C15H14N2O Molecular Weight: 238.289 Hazard Symbols: Xi WGKGermany: 3 HS Code: 29339900
More details are to be found here
BOC Sciences
USA
Description : Semaxanib is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. - Molecular Weight :238.28
- Melting Point :> 190ēC (dec.)
- Purity :98%
Molecular Formula : C15H14N2O Canonical SMILES : CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C InChI : InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-
InChIKey :
WUWDLXZGHZSWQZ-WQLSENKSSA-N
Appearance :
Yellow to Orange Solid Powder
Application :
Angiogenesis Inhibitors
Synonyms :
SU5416; SU-5416; SU 5416; Sugen 5416; semoxind
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Semaxanib is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. - Molecular Weight :238.28
- Melting Point :> 190ēC (dec.)
- Purity :98%
Molecular Formula : C15H14N2O Canonical SMILES : CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C InChI : InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-
InChIKey :
WUWDLXZGHZSWQZ-WQLSENKSSA-N
Appearance :
Yellow to Orange Solid Powder
Application :
Angiogenesis Inhibitors
Synonyms :
SU5416; SU-5416; SU 5416; Sugen 5416; semoxind
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Semaxanib is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. - Molecular Weight :238.28
- Melting Point :> 190ēC (dec.)
- Purity :98%
Molecular Formula : C15H14N2O Canonical SMILES : CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C InChI : InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-
InChIKey :
WUWDLXZGHZSWQZ-WQLSENKSSA-N
Appearance :
Yellow to Orange Solid Powder
Application :
Angiogenesis Inhibitors
Synonyms :
SU5416; SU-5416; SU 5416; Sugen 5416; semoxind
More details are to be found here
Detailed information on the suppliers of
SU 5416 |
details
details